You are here » Home » Companies » Company Overview » Sun Pharmaceuticals Industries Ltd

Sun Pharmaceuticals Industries Ltd.

BSE: 524715 Sector: Health care
NSE: SUNPHARMA ISIN Code: INE044A01036
BSE LIVE 15:47 | 29 Sep 737.05 -29.40
(-3.84%)
OPEN

769.95

HIGH

770.40

LOW

732.00

NSE LIVE 15:59 | 29 Sep 735.85 -28.95
(-3.79%)
OPEN

769.00

HIGH

770.00

LOW

732.00

OPEN 769.95
PREVIOUS CLOSE 766.45
VOLUME 305528
52-Week high 933.70
52-Week low 706.40
P/E 28.29
Mkt Cap.(Rs cr) 177393.19
Buy Price 738.00
Buy Qty 79.00
Sell Price 0.00
Sell Qty 0.00
OPEN 769.95
CLOSE 766.45
VOLUME 305528
52-Week high 933.70
52-Week low 706.40
P/E 28.29
Mkt Cap.(Rs cr) 177393.19
Buy Price 738.00
Buy Qty 79.00
Sell Price 0.00
Sell Qty 0.00

About Sun Pharmaceuticals Industries Ltd.

Sun Pharmaceuticals Industries Ltd

Sun Pharmaceutical Industries Ltd is an international specialty pharma company. The company manufactures and markets pharmaceutical formulations as branded generics as well as generics in India the United States and several other markets across the world. The company's business is divided into four segments: Indian Branded Generics US Generics International Branded Generics (ROW) and Active Pharma...> More

Sun Pharmaceuticals Industries Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   177,393
EPS - TTM () [*C] 26.05
P/E Ratio (X) [*C] 28.29
Face Value ()   1
Latest Dividend (%)   100.00
Latest Dividend Date 08 Sep 2016
Dividend Yield (%) 0.14
Book Value / Share () [*C] 130.48
P/B Ratio () [*C] 5.65
[*C] Consolidated     [*S] Standalone

Sun Pharmaceuticals Industries Ltd - Financial Results

Particulars ( cr) Jun 2016 Jun 2015 % Chg
Net Sales 8242.99 6761.49 21.91
Other Income 157.1 164.11 -4.27
Total Income 8400.09 6925.6 21.29
Total Expenses 5322.01 5678.82 -6.28
Operating Profit 3078.08 1246.78 146.88
Net Profit 2274.8 759.33 199.58
Equity Capital 240.67 240.62 -
> More on Sun Pharmaceuticals Industries Ltd Financials Results

Sun Pharmaceuticals Industries Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Sun Pharma.Inds. 737.05 -3.84 177393.19
Lupin 1469.50 -3.10 66296.49
Dr Reddy's Labs 3137.05 -2.12 53574.54
Cipla 600.90 -0.73 48324.38
> More on Sun Pharmaceuticals Industries Ltd Peer Group

Sun Pharmaceuticals Industries Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 54.97
Banks/FIs 4.52
FIIs 24.77
Insurance 1.92
Mutual Funds 3.74
Indian Public 6.26
Custodians 0.00
Other 3.81
> More on Sun Pharmaceuticals Industries Ltd Share Holding Pattern

Sun Pharmaceuticals Industries Ltd - Research Reports

Date Broker Action Price Report
02/08 Motilal Oswal Buy 829 PDF IconDetails
17/06 Prabhudas Lilladher Accumulate 754 PDF IconDetails
31/05 Motilal Oswal Buy 763 PDF IconDetails
31/05 Prabhudas Lilladher Accumulate 763 PDF IconDetails
13/02 Prabhudas Lilladher Accumulate 847 PDF IconDetails
> More on Sun Pharmaceuticals Industries Ltd Research Reports

Sun Pharmaceuticals Industries Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -6.29% -6.47% -3.29% -3.11%
1 Month -2.89% -3.09% -0.27% -0.19%
3 Month -4.44% -4.47% 4.07% 4.72%
6 Month -7.18% -7.36% 11.76% 13.09%
1 Year -13.33% -13.25% 7.95% 9.54%
3 Year 24.98% 24.75% 41.06% 47.28%

Sun Pharmaceuticals Industries Ltd - STOCK STRENGTH

Today's Low/High 732.00
770.40
Week Low/High 732.00
792.00
Month Low/High 732.00
818.00
YEAR Low/High 706.40
934.00
All TIME Low/High 1.65
1201.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard